Publications by authors named "Mirjam B Zeisel"

Claim this Profile
M
miR-21p-5p coordinates biological pathways to promote MASLD progression.
Patricia Aspichueta, Mirjam B Zeisel

Liver Int· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment.
Natascha Roehlen, Marion Muller, Zeina Nehme, Emilie Crouchet, Frank Jühling, Mirjam B Zeisel

J Hepatol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity.
Natascha Roehlen, Antonio Saviano, Houssein El Saghire, Emilie Crouchet, Zeina Nehme, Mirjam B Zeisel

Sci Transl Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery.
Emilie Crouchet, Simonetta Bandiera, Naoto Fujiwara, Shen Li, Hussein El Saghire, Mirjam B Zeisel

Nat Commun· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The lncRNAs in HBV-Related HCCs: Targeting Chromatin Dynamics and Beyond.
Vincenzo Alfano, Mirjam B Zeisel, Massimo Levrero, Francesca Guerrieri

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host Epigenetic Alterations and Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Mirjam B Zeisel, Francesca Guerrieri, Massimo Levrero

J Clin Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma.
Frank Jühling, Nourdine Hamdane, Emilie Crouchet, Shen Li, Houssein El Saghire, Mirjam B Zeisel

Gut· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C Virus Entry: An Intriguingly Complex and Highly Regulated Process.
Che C Colpitts, Pei-Ling Tsai, Mirjam B Zeisel

Int J Mol Sci· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional microRNA screen uncovers O-linked N-acetylglucosamine transferase as a host factor modulating hepatitis C virus morphogenesis and infectivity.
Katharina Herzog, Simonetta Bandiera, Sophie Pernot, Catherine Fauvelle, Frank Jühling, Mirjam B Zeisel

Gut· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined small molecule and loss-of-function screen uncovers estrogen receptor alpha and CAD as host factors for HDV infection and antiviral targets.
Eloi R Verrier, Amélie Weiss, Charlotte Bach, Laura Heydmann, Vincent Turon-Lagot, Mirjam B Zeisel

Gut· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon-Induced Transmembrane Proteins Mediate Viral Evasion in Acute and Chronic Hepatitis C Virus Infection.
Florian Wrensch, Gaëtan Ligat, Laura Heydmann, Catherine Schuster, Mirjam B Zeisel

Hepatology· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin Resistance.
Nassim Dali-Youcef, Michel Vix, Federico Costantino, Houssein El-Saghire, Benoit Lhermitte, Mirjam B Zeisel

Hepatol Commun· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease Development.
Joachim Lupberger, Tom Croonenborghs, Armando Andres Roca Suarez, Nicolaas Van Renne, Frank Jühling, Mirjam B Zeisel

Gastroenterology· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response.
Nourdine Hamdane, Frank Jühling, Emilie Crouchet, Houssein El Saghire, Christine Thumann, Mirjam B Zeisel

Gastroenterology· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tight junction proteins in gastrointestinal and liver disease.
Mirjam B Zeisel, Punita Dhawan, Thomas F Baumert

Gut· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo combination of human anti-envelope glycoprotein E2 and -Claudin-1 monoclonal antibodies for prevention of hepatitis C virus infection.
Laurent Mailly, Florian Wrensch, Laura Heydmann, Catherine Fauvelle, Nicolas Brignon, Mirjam B Zeisel

Antiviral Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B Virus Evasion From Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase Sensing in Human Hepatocytes.
Eloi R Verrier, Seung-Ae Yim, Laura Heydmann, Houssein El Saghire, Charlotte Bach, Mirjam B Zeisel

Hepatology· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular Carcinoma.
Marie-Laure Plissonnier, Katharina Herzog, Massimo Levrero, Mirjam B Zeisel

Viruses· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C Virus (HCV)-Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design.
Florian Wrensch, Emilie Crouchet, Gaetan Ligat, Mirjam B Zeisel, Zhen-Yong Keck

Front Immunol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis.
Nicolaas Van Renne, Armando Andres Roca Suarez, Francois H T Duong, Claire Gondeau, Diego Calabrese, Mirjam B Zeisel

Gut· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Risk of hepatocellular carcinoma after hepatitis C virus cure with direct-acting antivirals: the next challenges].
Nourdine Hamdane, Thomas F Baumert, Mirjam B Zeisel

Med Sci (Paris)· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape.
Che C Colpitts, Rajiv G Tawar, Laurent Mailly, Christine Thumann, Laura Heydmann, Mirjam B Zeisel

Gut· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host-targeting therapies for hepatitis C virus infection: current developments and future applications.
Emilie Crouchet, Florian Wrensch, Catherine Schuster, Mirjam B Zeisel, Thomas F Baumert

Therap Adv Gastroenterol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward novel immunocompetent animal models for hepatitis B virus infection.
Laurent Mailly, Mirjam B Zeisel, Thomas F Baumert

Hepatology· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P36 determines host cell receptor usage during sporozoite invasion.
Giulia Manzoni, Carine Marinach, Selma Topçu, Sylvie Briquet, Morgane Grand, Mirjam B Zeisel

Elife· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis